Compare Iron Mountain Inc (IRM) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iron Mountain Inc vs Twist Bioscience Corp — how do they compare? Iron Mountain Inc trades at $113.5 (market cap $34.46B), while Twist Bioscience Corp trades at $157.06 (market cap $10.32B). The key difference: Iron Mountain Inc is far larger — about 3.3× Twist Bioscience Corp's market cap, and Iron Mountain Inc pays a 2.99% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Iron Mountain Inc for 80 Days and Twist Bioscience Corp for 27 Days on average.
| IRM | TWST | |
|---|---|---|
Market Cap | $34.46B | $10.32B |
Volume | 1,379,608 | 5,894,998 |
Sector | Real Estate | Health |
52-Week High | $133.06 | $205.00 |
52-Week Low | $78.86 | $25.45 |
Typical Hold Time | 80 Days | 27 Days |
Enterprise Value | $53.87B | $10.24B |
Dividend Yield | 2.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Iron Mountain (IRM) trades at $112.97, down 3.03% today, with strong technical bullish signals and consistent earnings beats. The stock shows robust revenue growth from $5.1B in 2022 to $6.9B in 2025, though net margins have compressed. Recent developments highlight expansion in data centers and digital solutions, with a 300MW pipeline target. Analyst consensus remains bullish with a $142.75 price target, representing 26% upside potential from current levels.
IRM presents a compelling growth story in data center expansion and digital transformation, but faces significant debt burden with 79% debt-to-asset ratio. While institutional ownership is growing and earnings consistently exceed expectations, high valuation multiples and declining profit margins warrant caution. The stock's near-term performance will depend on successful execution of digital initiatives and debt management.
TWST trades at $152.05, down 8.94% over 24 hours, with a bearish technical signal and negative cash flows. Revenue growth is strong, reaching $376.57 million in 2025, but profitability remains elusive with a net income margin of -31.66%. Recent news highlights a partnership with Lilly TuneLab for AI-driven drug discovery, providing a potential growth catalyst amid ongoing losses.
The outlook is mixed; analyst consensus is bullish with a $145.20 price target, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on the company's ability to monetize its AI collaborations and achieve profitability, while downside risks include cash burn and competitive pressures in the biotech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iron Mountain Inc
Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business
Read more on IRM →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
